Cancers of unknown primary diagnosed during hospitalization: a population-based study

Article English OPEN
Jones, William ; Allardice, Gwen ; Scott, Iona ; Oien, Karin ; Brewster, David ; Morrison, David S. (2017)
  • Publisher: Springer Nature
  • Journal: BMC Cancer, volume 17 (eissn: 1471-2407)
  • Related identifiers: doi: 10.1186/s12885-017-3083-1, pmc: PMC5282907
  • Subject: Occult primary neoplasms | Unknown primary tumor | Research Article | Genetics | Cancer Research | Oncology

Background: \ud Cancers of Unknown Primary (CUP) are the 3-4th most common causes of cancer death and recent clinical guidelines recommend that patients should be directed to a team dedicated to their care. Our aim was to inform the care of patients diagnosed with CUP during hospital admission.\ud \ud Methods: \ud Descriptive study using hospital admissions (Scottish Morbidity Record 01) linked to cancer registrations (ICD-10 C77-80) and death records from 1998 to 2011 in West of Scotland, UK (population 2.4 m). Cox proportional hazards models were used to assess effects of baseline variables on survival.\ud \ud Results: \ud Seven thousand five hundred ninety nine patients were diagnosed with CUP over the study period, 54.4% female, 67.4% aged ≥ 70 years, 36.7% from the most deprived socio-economic quintile. 71% of all diagnoses were made during a hospital admission, among which 88.6% were emergency presentations and the majority (56.3%) were admitted to general medicine. Median length of stay was 15 days and median survival after admission 33 days. Non-specific morphology, emergency admission, age over 60 years, male sex and admission to geriatric medicine were all associated with poorer survival in adjusted analysis.\ud \ud Conclusions: \ud Patients with a diagnosis of CUP are usually diagnosed during unplanned hospital admissions and have very poor survival. To ensure that patients with CUP are quickly identified and directed to optimal care, increased surveillance and rapid referral pathways will be required.
  • References (15)
    15 references, page 1 of 2

    1. National Institute for Health and Clinical Excellence: Metastic malignant disease of unknown primary origin: Diagnosis and management of metastatic malignant disease of unknown primary origin. London: NICE; 2010.

    2. Shu X, Sundquist K, Sundquist J, Hemminki K. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev. 2012;21(3):281-8.

    3. Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008;32(4):383-9.

    4. Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109(5):1318-24.

    5. Randen M, Rutqvist LE, Johansson H. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Acta Oncol. 2009;48(6):915-20.

    6. Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012; 379(9824):1428-35.

    7. Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Cancer Epidemiol. 2014;38(3):227-34.

    8. Cancer Research UK and National Cancer Intelligence Network. Cancer of unknown primary NCIN and CR-UK data briefing. 2013.

    9. Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G, Group EGW. Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22 Suppl 6:vi64-8.

    10. National Cancer Intelligence Network. Routes to diagnosis: cancer of unknown primary - NCIN data briefing. 2014.

  • Metrics
    No metrics available
Share - Bookmark